In the cystoscopic follow-up of non-muscle-invasive transitional cell carcinoma, NMP-22 works for high grades, but unreliable in low grades and upper urinary tract tumors.


Coskuner E. R. , Cevik I., Ozkan A., DİLLİOĞLUGİL Ö., Akdas A.

International urology and nephrology, vol.44, no.3, pp.793-8, 2012 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 3
  • Publication Date: 2012
  • Doi Number: 10.1007/s11255-012-0144-x
  • Title of Journal : International urology and nephrology
  • Page Numbers: pp.793-8

Abstract

Two percent of the bladder non-muscle-invasive (NMI) transitional cell carcinomas (TCC) are associated with upper urinary tract (UUT) TCC. We evaluated the role of nuclear matrix protein-22 (NMP-22) (BladderChek(A (R))) test in the diagnosis of lower urinary tract and UUT-TCC.